Viral Diseases: Current Research and Future Directions, Second Edition

Dear Colleagues,

This Special Issue is a continuation of our previous Special Issue, titled "Viral Diseases: Current Research and Future Directions". Viral diseases continue to pose significant challenges to global public health, necessitating ongoing research efforts to understand their complex mechanisms and develop effective prevention and treatment strategies. Viruses are ubiquitous pathogens that can cause a diverse range of diseases, from the common cold to more severe conditions, including AIDS and COVID-19. In addition to acute infections, certain viruses have the potential to induce chronic conditions, including cancer. Viral-induced cancers, such as those caused by human papillomavirus (HPV), hepatitis B virus (HBV), and Epstein–Barr virus (EBV), represent a significant global health burden. Understanding the mechanisms by which these viruses contribute to oncogenesis is essential for developing targeted therapies and preventive strategies. In this Special Issue, we bring together a collection of articles that delve into various aspects of viral diseases, including their role in cancer development. From fundamental studies elucidating the molecular mechanisms of viral replication and pathogenesis to clinical research exploring novel diagnostic tools and therapeutic interventions, each contribution provides valuable insights into combating viral infections and associated health complications. Moreover, this Special Issue will emphasize the interdisciplinary nature of viral disease research, spanning fields such as virology, immunology, epidemiology, and computational biology. As we navigate the complex landscape of viral diseases, it is crucial to not only focus on the immediate challenges but also anticipate and prepare for future threats. Therefore, this Special Issue will also explore innovative approaches and technologies that hold promise for advancing our understanding of viral pathogenesis and transforming the landscape of disease prevention and control. By sharing knowledge, expertise, and innovative solutions, we can collectively work toward a world where the impact of viral infections is minimized and communities are better equipped to respond to public health challenges.

Dr. Sherif T.S. Hassan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.